Daewoong Pharmaceutical is expanding its distribution channels into consumer living spaces.
On June 15, Daewoong announced that it has signed a memorandum of understanding (MOU) with Arc, a company specializing in AI-based chronic disease complication screening, to collaborate on the SANVEL health management service project based on an AI healthcare lounge in residential complexes.
The agreement aims to combine the digital healthcare capabilities and AI technology of both companies to create a service that allows residents to continuously monitor and manage their health in their daily living spaces.
SANVEL will be an AI healthcare lounge established within apartment communities. Residents will be able to measure their health status in the lounge, where AI analysis will help identify health risk signals at an early stage. The lounge is designed to facilitate connections to medical services as needed.
Under the agreement, Daewoong will provide health supplements, digital healthcare capabilities, and chronic disease management solutions, while Arc will handle service planning, development, operations, sales, and marketing. The two companies plan to continue discussions on customized services and specialized programs in the future.
With this collaboration, Daewoong is set to expand its digital healthcare business from a focus on hospitals and health check-up centers to residential complexes. The company aims to achieve annual sales of 300 billion won in its digital healthcare sector this year.
Park Hyung-cheol, head of Daewoong's ETC Marketing Division, stated, "This is the starting point for expanding our healthcare capabilities into living spaces. We will provide an environment where people can monitor and prevent health issues in their daily lives."
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.